Vanillin Mitigates the MPTP-Induced α-Synucleinopathy in a Mouse Model of Parkinson's Disease: Insights into the Involvement of Wnt/β-Catenin Signaling
Journal of Integrative Neuroscience · 2024
DOI: 10.31083/j.jin2309175 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Integrative Neuroscience, 2024. Verfasst von Linchi Rani und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, 110067 New Delhi, Delhi, India. Hauptthemen laut MEDLINE: alpha-Synuclein, Benzaldehydes, Disease Models, Animal, Neuroprotective Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology (DBT), Govt. of India, Ministry of Science and Technology (Govt. of India).
Abstract (Originalsprache)
Background
The abnormal aggregation of α-synuclein (α-syn) in the substantia nigra pars compacta (SNpc) region of the brain is characteristic of Parkinson's disease (PD), leading to the selective demise of neurons. Modifications in the post-translational processing of α-syn, phosphorylation at Ser129 in particular, are implicated in α-syn aggregation and are considered key hallmarks of PD. Furthermore, dysregulated Wnt/β-catenin signaling, influenced by glycogen synthase kinase-3 beta (GSK-3β), is implicated in PD pathogenesis. Inhibition of GSK-3β holds promise in promoting neuroprotection by enhancing the Wnt/β-catenin pathway.
Methods
In our previous study utilizing 1-methyl-4-phenylpyridinium (MPP+)-administered differentiated SH-SY5Y cells and a PD mouse model, we explored Vanillin's neuroprotective properties and related mechanisms against neuronal loss induced by MPP+/1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration. In the current study, we elucidated the mitigating effects of Vanillin on motor impairments, P-Ser129-α-syn expression, Wnt/β-catenin signaling, and autophagic neuron death induced by MPTP in a mouse model of PD by performing motor function tests, western blot analysis and immunostaining.
Results
Our results show that Vanillin effectively modulated the motor dysfunctions, GSK-3β expression, and activity, activated the Wnt/β-catenin signaling, and reduced autophagic neuronal demise in the MPTP-lesioned mice, highlighting its neuroprotective effects.
Conclusions
These findings underscore the complex interplay between α-syn pathology, GSK-3β, Wnt/β-catenin signaling, and autophagic-cell death in PD pathogenesis. Targeting these pathways, particularly with Vanillin, can be a promising therapeutic strategy for restoring dopaminergic (DA-ergic) neuronal homeostasis and slowing the progression of PD. Further research is crucial to resolving existing disputes and translating these discoveries into effective therapeutic interventions for PD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cellular and Molecular Neurobiology, School of Life Sciences, Jawaharlal Nehru University, 110067 New Delhi, Delhi, India.
Förderung
- Department of Biotechnology (DBT), Govt. of India
- Ministry of Science and Technology (Govt. of India)
Zitieren
APA
Rani, L., & Mondal, A. C. (2024). Vanillin Mitigates the MPTP-Induced α-Synucleinopathy in a Mouse Model of Parkinson's Disease: Insights into the Involvement of Wnt/β-Catenin Signaling. Journal of Integrative Neuroscience. https://doi.org/10.31083/j.jin2309175
Vancouver
Rani L, Mondal AC. Vanillin Mitigates the MPTP-Induced α-Synucleinopathy in a Mouse Model of Parkinson's Disease: Insights into the Involvement of Wnt/β-Catenin Signaling. Journal of Integrative Neuroscience. 2024. doi:10.31083/j.jin2309175
BibTeX
@article{Rani2024,
author = {Rani, Linchi and Mondal, Amal Chandra},
title = {Vanillin Mitigates the MPTP-Induced α-Synucleinopathy in a Mouse Model of Parkinson's Disease: Insights into the Involvement of Wnt/β-Catenin Signaling},
journal = {Journal of Integrative Neuroscience},
year = {2024},
doi = {10.31083/j.jin2309175}
}
EUVIMED